Conn's Current Therapy 2010 provides concise and easy-to-use guidance on the latest advances in therapeutics for common complaints and diagnoses. Edward T. Bope, MD; Robert E. Rakel, MD; and Rick D. Kellerman offer their expertise and the knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. Tap into recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much more to stay on top of current treatment practices. With the full text online at expertconsult.com, you'll have the information you need right at your fingertips for easy access! Provides access to the full contents of the text online at expertconsult.com. Discusses recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much so you can stay on top of current treatment practices. Contains important diagnostic criteria in each chapter because correct diagnoses lead to the delivery of effective treatment. Features acknowledged expert contributors for each chapter so you know that you are getting the best and most practical and accurate advice. Presents management methods used by international experts to provide you with best practices from around the world. Covers most common major presenting symptoms in a section on symptomatic care to assure that your patients can get the best possible treatment while tests are being performed. Incorporates the latest information on recently-approved and soon-to-be-approved drugs so you are aware of all treatment options. Includes the ICD-9 list of common diseases and codes on end papers to enable you and your staff to accurately code for reimbursement.
In: Swerdlow S, Campo E, Lee Harris N, et al., WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. ... Greenberg PL. The smoldering myeloid leukemic states: Clinical and biologic features. Blood 1983;61:1035–44.
In: Swerdlow S, Campo E, Lee Harris N, et al., WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008. p. 88–103. Cutler CS, Lee SJ, Greenberg P, et al. A decision analysis of allogeneic ...
Lund–Browder classification of burn size. Head Neck ... A much more precise estimate of burn area is provided by the Lund–Browder diagram (Figure 2). By drawing in the areas that are burned, the burn area necessary for calculating ...
In Swerdlow S, Campo E, Lee Harris N, et al, editors: WHO Classification of Tumors of Hematopoietic ... Cutler CS, Lee SJ, Greenberg P, et al: A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic ...
In Bope ET, Kellerman RD, Rakel RE, editors: Conn's Current Therapy 2011, Philadelphia, 2011, Saunders, pp • Hematologic complications: Aspartate aminotransferase (AST) 74–78. Gür A, Geyik MF, Dikici B, et al: Complications of ...
Fluorescein (Fluorets) should be used to identify corneal injury. Chemical burns to the eyes should be rinsed with copious amounts of saline. Burns Figure 2. Lund–Browder classification of burn size. 2.5 2.5 1.
With this easy-to-use guide, readers can tap into recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently approved and soon-to-be-approved drugs, and more to stay on top of current treatment ...
Family medicine experts, Drs. Edward T. Bope and Rick D. Kellerman present the expertise and knowledge of hundreds of skilled international leaders on evidence-based clinical management options.
Morales P, Baum AE: Therapeutic alternatives for the Mallory-Weiss tear. Curr Treat Options Gastroenterol 6(1):75–83, 2003. Navarro VJ, Garcia-Tsao G: Variceal hemorrhage. Crit Care Clin 11(2): 391–414, 1995.
Levine, G. N., Bates, E. R., Bittl, J. A., et al. (2016). 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American ...